Vincerx Pharma (NASDAQ:VINC – Get Free Report) and Leap Therapeutics (NASDAQ:LPTX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Insider & Institutional Ownership 44.0% of Vincerx […]

Volatility & Risk Vincerx Pharma has a beta of 1.58, meaning that its stock price is 58% more volatile than the S&P 500. Comparatively, Trevena has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Profitability This table compares Vincerx Pharma and Trevena’s net margins, return on […]